Effects of Social Media Usage on Pain Catastrophizing and Disease Impact in Female Patients With Fibromyalgia Syndrome

NCT05883215 | Unknown

• 1 other identifier: FMS1
• Study Type: observational
• Target: 73
• Locations: 0 countries
• Sites: N/A

Brief Summary

The aim of this study is to investigate the effects of social media usage on pain catastrophizing and disease impact in female individuals diagnosed with fibromyalgia syndrome.

Conditions

Fibromyalgia

Outcome Measures

Primary Outcomes (3)

• Correlation between social media use and pain catastrophizing

  The possible correlation between the results obtained with the social media integration scale and the results obtained with the pain catastrophizing scale will be investigated with statistical methods.

  1 day

• Correlation between social media use and disease impact

  The possible correlation between the results obtained with the social media integration scale and the results obtained with the fibromyalgia impact questionnaire will be investigated with statistical methods.

  1 day

• Correlation between social media use and anxiety

  The possible correlation between the results obtained with the social media integration scale and the results obtained with the Beck Anxiety Inventory will be investigated with statistical methods.

  1 day

Study Arms (1)

Female Patients Diagnosed with Fibromyalgia Syndrome

Female patients who give consent to participate and are diagnosed with fibromyalgia syndrome.

Other: Pain catastrophizing scale; Other: Beck Anxiety Inventory; Other: Social Media Use Integration Scale; Other: Fibromyalgia Impact Questionnaire

Interventions

Pain catastrophizing scale OTHER

The pain catastrophizing scale is a self-report questionnaire used to assess an individual's tendency to engage in catastrophic thinking when experiencing pain. It measures the extent to which a person magnifies, feels helpless, and feels unable to cope with pain. The scale typically consists of several items that ask individuals to rate the degree to which they experience specific thoughts or emotions related to pain catastrophizing, such as "I worry all the time about whether the pain will end" or "I feel like I can't stand it anymore." Participants provide responses on a Likert scale indicating the intensity or frequency of their agreement with each statement. The scale helps researchers and healthcare professionals gain insights into an individual's cognitive and emotional responses to pain, which can have implications for pain management strategies and overall well-being.

Female Patients Diagnosed with Fibromyalgia Syndrome

Beck Anxiety Inventory OTHER

Beck Anxiety Inventory" (BAI), which is designed to measure the severity of anxiety symptoms in individuals. The BAI is a self-report questionnaire consisting of 21 items that assess various symptoms of anxiety, such as nervousness, fear, and physiological manifestations of anxiety. Participants rate the intensity of their symptoms over the past week on a scale ranging from 0 (not at all) to 3 (severely). The scores obtained on the BAI can help clinicians and researchers evaluate the presence and severity of anxiety symptoms, monitor changes over time, and guide treatment decisions. It is important to note that the BAI is not a diagnostic tool but rather a measure of self-reported anxiety symptoms.

Female Patients Diagnosed with Fibromyalgia Syndrome

Social Media Use Integration Scale OTHER

The Social Media Use Integration Scale (SMUIS) is a self-report measure that assesses the degree to which individuals integrate social media into their daily lives. It aims to capture the extent to which individuals incorporate social media use into various aspects of their routines, behaviors, and identity. The scale typically consists of items that assess factors such as the frequency and duration of social media use, the importance and impact of social media on personal relationships, the integration of social media into daily activities, and the emotional connection to social media.

Female Patients Diagnosed with Fibromyalgia Syndrome

Fibromyalgia Impact Questionnaire OTHER

The Fibromyalgia Impact Questionnaire (FIQ) is a widely used self-report measure specifically designed to assess the impact of fibromyalgia on various aspects of a person's life. It is a multidimensional questionnaire that evaluates the physical functioning, social functioning, and overall well-being of individuals with fibromyalgia. The FIQ typically consists of items that ask individuals to rate the impact of fibromyalgia on their ability to perform daily activities, such as work, household chores, and recreational activities. It also assesses the severity of fibromyalgia symptoms, including pain, fatigue, sleep disturbances, and cognitive difficulties. Additionally, the questionnaire may include items related to emotional well-being, social support, and overall quality of life.

Female Patients Diagnosed with Fibromyalgia Syndrome

Eligibility Criteria

• Age: 18 Years - 65 Years
• Gender Eligibility Details: Participant eligibility is based on gender identity.
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Female patients with fibromyalgia syndrome diagnosis who gave consent to participate.

You may qualify if:

• Giving consent.
• Being diagnosed with Fibromyalgia syndrome
• Being female

You may not qualify if:

• Not giving consent.
• Any disability or illness that may prevent filling out the form or communicating.

Sponsors & Collaborators

• Uskudar State Hospital: lead
• Başakşehir Çam & Sakura City Hospital: collaborator
• Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey: collaborator

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Neuromuscular Diseases; Nervous System Diseases

Study Officials

• Mustafa H Temel, M.D.

  Uskudar State Hospital

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Mustafa H Temel, M.D.

CONTACT

+905342714872; mhuseyintemel@gmail.com

Fatih Bağcıer, M.D.

CONTACT

05442429042; bagcier_42@hotmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER GOV
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 20, 2023
• First Posted: May 31, 2023
• Study Start: October 1, 2023
• Primary Completion: June 1, 2024
• Study Completion: December 1, 2024
• Last Updated: May 31, 2023

Record last verified: 2023-05